E. Scheers

发表

Prediction of the drug–drug interaction potential of the α1‐acid glycoprotein bound, CYP3A4/CYP2C9 metabolized oncology drug, erdafitinib

M. Monshouwer, I. Poggesi, L. D. De Zwart, 2021, CPT: pharmacometrics & systems pharmacology.

Absolute oral bioavailability and pharmacokinetics of canagliflozin: A microdose study in healthy participants

P. Rothenberg, J. Murphy, H. Stieltjes, 2015, Clinical pharmacology in drug development.

Absorption, Metabolism, and Excretion of Oral 14C Radiolabeled Ibrutinib: An Open-Label, Phase I, Single-Dose Study in Healthy Men

L. Leclercq, J. Murphy, J. de Jong, 2015, Drug Metabolism and Disposition.

Metabolism and Excretion of Canagliflozin in Mice, Rats, Dogs, and Humans

Mark D. Johnson, F. Cuyckens, D. C. Evans, 2014, Drug Metabolism and Disposition.

Cytotoxicity of the MEIC Reference Chemicals in Antioxidant-enriched Rat Hepatoma-derived Fa32 cells

C. Smit, E. Scheers, P. Dierickx, 2001, Alternatives to laboratory animals : ATLA.

Toxicological Evaluation of Waste-Water Samples to Appropriately Sensitized Cultured Fathead Minnow Cells Compared with the Microtox Assay

E. Scheers, P. Dierickx, C. van der Wielen, 2002, Bulletin of environmental contamination and toxicology.

In vitro and physiologically‐based pharmacokinetic based assessment of drug–drug interaction potential of canagliflozin

Mark D. Johnson, L. Leclercq, S. Dallas, 2017, British journal of clinical pharmacology.

In vitro long-term cytotoxicity testing of 27 MEIC chemicals on Hep G2 cells and comparison with acute human toxicity data.

B Ekwall, B. Ekwall, P J Dierickx, 2001, Toxicology in vitro : an international journal published in association with BIBRA.

In vitro metabolism of canagliflozin in human liver, kidney, intestine microsomes, and recombinant uridine diphosphate glucuronosyltransferases (UGT) and the effect of genetic variability of UGT enzymes on the pharmacokinetics of canagliflozin in humans

R. Favis, D. Devineni, E. Scheers, 2015, Journal of clinical pharmacology.

Cytotoxicity of Pyrethroid Insecticides in Rat Hepatoma-Derived Fa32 Cells

C. Smit, E. Scheers, P. Dierickx, 2001 .

Development of an In Vitro Test Battery for the Estimation of Acute Human Systemic Toxicity: An Outline of the EDIT Project

B. Isomaa, K. Kurppa, A. Kolman, 2002, Alternatives to laboratory animals : ATLA.

Metabolism and disposition in rats, dogs, and humans of erdafitinib, an orally administered potent pan-fibroblast growth factor receptor (FGFR) tyrosine kinase inhibitor

I. Poggesi, L. Leclercq, F. Cuyckens, 2020, Xenobiotica; the fate of foreign compounds in biological systems.